Mechanism of YTHDF2 ‐Mediated Epigenetic Modification in the Proliferation and Invasion of Renal Cell Carcinoma Cells
BioFactors · 2026-03 · 52 (2)
DOI: 10.1002/biof.70099 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, online erschienen am 24.04.2026. Verfasst von Xiaomeng Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Carcinoma, Renal Cell, Kidney Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Beijing Bethune Charitable Foundation.
Abstract (Originalsprache)
Renal cell carcinoma (RCC) ranks as the most prevalent form of urogenital cancer. This research aims to investigate the role of YTHDF2 in the RCC progression and identify new therapeutic targets for RCC. YTHDF2, E2F2, and CORO6 were assayed via qRT‐PCR and Western blot. YTHDF2 was downregulated in RCC cells, while E2F2 and CORO6 were upregulated. After overexpressing YTHDF2 in RCC cells, cell viability, proliferation, invasion, and migration were measured. m6A levels were assessed. The binding of YTHDF2 to E2F2 was detected. The E2F2 mRNA stability was detected. The binding of E2F2 to the CORO6 promoter was analyzed. Overexpression of E2F2 or CORO6 was combined with YTHDF2 overexpression to validate the mechanism. Tumor growth and metastasis were observed. Results confirmed that YTHDF2 overexpression decreased cell proliferation, invasion, and migration. YTHDF2 bound to the m6A sites on E2F2 mRNA, promoted E2F2 degradation, and inhibited E2F2 expression. E2F2 bound to the CORO6 promoter to enhance CORO6 expression. Overexpression of E2F2 or CORO6 partially reversed the suppressive effects of YTHDF2 overexpression on RCC cell proliferation and invasion. YTHDF2 overexpression suppressed tumor growth and metastasis. In conclusion, YTHDF2 overexpression suppresses RCC progression by inhibiting E2F2 expression and reducing CORO6 expression via m6A modification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CNRS, Paris, France.
ORCID-Profile: Yingying Zhu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Beijing Bethune Charitable Foundation
Zitieren
APA
Zhang, X., Zhang, Y., Yang, X., Fan, Y., & Zhu, Y. (2026). Mechanism of YTHDF2 ‐Mediated Epigenetic Modification in the Proliferation and Invasion of Renal Cell Carcinoma Cells. BioFactors, 52(2). https://doi.org/10.1002/biof.70099
Vancouver
Zhang X, Zhang Y, Yang X, Fan Y, Zhu Y. Mechanism of YTHDF2 ‐Mediated Epigenetic Modification in the Proliferation and Invasion of Renal Cell Carcinoma Cells. BioFactors. 2026;52(2). doi:10.1002/biof.70099
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaomeng and Zhang, Yan and Yang, Xin and Fan, Ye and Zhu, Yingying},
title = {Mechanism of YTHDF2 ‐Mediated Epigenetic Modification in the Proliferation and Invasion of Renal Cell Carcinoma Cells},
journal = {BioFactors},
year = {2026},
volume = {52},
number = {2},
doi = {10.1002/biof.70099}
}
EUVIMED